144 related articles for article (PubMed ID: 26600128)
1. Vitamin E Attenuates the Progression of Non-Alcoholic Fatty Liver Disease Caused by Partial Hepatectomy in Mice.
Karimian G; Kirschbaum M; Veldhuis ZJ; Bomfati F; Porte RJ; Lisman T
PLoS One; 2015; 10(11):e0143121. PubMed ID: 26600128
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease.
Jorgačević B; Mladenović D; Ninković M; Prokić V; Stanković MN; Aleksić V; Cerović I; Vukićević RJ; Vučević D; Stanković M; Radosavljević T
Hum Exp Toxicol; 2014 Jul; 33(7):701-9. PubMed ID: 24130212
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
Presa N; Clugston RD; Lingrell S; Kelly SE; Merrill AH; Jana S; Kassiri Z; Gómez-Muñoz A; Vance DE; Jacobs RL; van der Veen JN
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):14-25. PubMed ID: 30300671
[TBL] [Abstract][Full Text] [Related]
4. Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease.
Yamamoto H; Kanno K; Ikuta T; Arihiro K; Sugiyama A; Kishikawa N; Tazuma S
J Hepatobiliary Pancreat Sci; 2016 May; 23(5):260-9. PubMed ID: 26880573
[TBL] [Abstract][Full Text] [Related]
5. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
6. Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy.
Valdecantos MP; Ruiz L; Pardo V; Castro-Sanchez L; García-Monzón C; Lanzón B; Rupérez J; Barbas C; Naylor J; Trevaskis JL; Grimsby J; Rondinone CM; Valverde ÁM
Sci Rep; 2018 Nov; 8(1):16461. PubMed ID: 30405191
[TBL] [Abstract][Full Text] [Related]
7. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
[TBL] [Abstract][Full Text] [Related]
8. Endothelial autophagy is not required for liver regeneration after partial hepatectomy in mice with fatty liver.
Hammoutene A; Tanguy M; Calmels M; Pravisani R; Albuquerque M; Casteleyn C; Slimani L; Sadoine J; Boulanger CM; Paradis V; Gilgenkrantz H; Rautou PE
Liver Int; 2023 Oct; 43(10):2309-2319. PubMed ID: 37403133
[TBL] [Abstract][Full Text] [Related]
9. L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet.
Mollica G; Senesi P; Codella R; Vacante F; Montesano A; Luzi L; Terruzzi I
Dig Liver Dis; 2020 Mar; 52(3):314-323. PubMed ID: 31607566
[TBL] [Abstract][Full Text] [Related]
10. Dietary glycotoxins exacerbate progression of experimental fatty liver disease.
Leung C; Herath CB; Jia Z; Goodwin M; Mak KY; Watt MJ; Forbes JM; Angus PW
J Hepatol; 2014 Apr; 60(4):832-8. PubMed ID: 24316518
[TBL] [Abstract][Full Text] [Related]
11. New Potential Biomarker Proteins for Alcoholic Liver Disease Identified by a Comparative Proteomics Approach.
Lee SJ; Lee DE; Kang JH; Nam MJ; Park JW; Kang BS; Lee DS; Lee HS; Kwon OS
J Cell Biochem; 2017 May; 118(5):1189-1200. PubMed ID: 27764896
[TBL] [Abstract][Full Text] [Related]
12. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.
Chen T; Zhong FJ; Hong YM; Su WJ; Zhuang LL; Qiu LX
Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
14. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM
Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427
[TBL] [Abstract][Full Text] [Related]
15. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice.
Ideta T; Shirakami Y; Miyazaki T; Kochi T; Sakai H; Moriwaki H; Shimizu M
Int J Mol Sci; 2015 Dec; 16(12):29207-18. PubMed ID: 26670228
[TBL] [Abstract][Full Text] [Related]
16. Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice.
Ling J; Chaba T; Zhu LF; Jacobs RL; Vance DE
Hepatology; 2012 Apr; 55(4):1094-102. PubMed ID: 22095799
[TBL] [Abstract][Full Text] [Related]
17. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
[TBL] [Abstract][Full Text] [Related]
18. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.
Pisonero-Vaquero S; Martínez-Ferreras Á; García-Mediavilla MV; Martínez-Flórez S; Fernández A; Benet M; Olcoz JL; Jover R; González-Gallego J; Sánchez-Campos S
Mol Nutr Food Res; 2015 May; 59(5):879-93. PubMed ID: 25712622
[TBL] [Abstract][Full Text] [Related]
19. Mainstream cigarette smoke accelerates the progression of nonalcoholic steatohepatitis by modulating Kupffer cell-mediated hepatocellular apoptosis in adolescent mice.
Park S; Kim JW; Yun H; Choi SJ; Lee SH; Choi KC; Lim CW; Lee K; Kim B
Toxicol Lett; 2016 Aug; 256():53-63. PubMed ID: 27180087
[TBL] [Abstract][Full Text] [Related]
20. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
Tan DY; Shi HY; Li CP; Zhong XL; Kang M
World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
